Drug Discovery News
-
Senhwa Biosciences, NIH to co-develop COVID-19 drug
Drug Discovery | News | 0 Comment | 27 Apr, 2020
Taiwan headquartered Senhwa Biosciences Inc announced that it has partnered with the US National Institutes of Health (N...Read more
-
Esperion & Otsuka to develop treatment for hypercholesterolemia
Drug Discovery | News | 0 Comment | 23 Apr, 2020
US based Esperion has announced that the company has entered into a collaboration agreement with Otsuka Pharmaceutic...Read more
-
Insilico collaborates with BI for discovering therapeutic targets
Drug Discovery | News | 0 Comment | 23 Apr, 2020
Hong Kong headquartered Insilico Medicine has announced that it has entered into a research collaboration with Boehringe...Read more
-
Combined treatment from existing drugs might combat COVID-19
Drug Discovery | News | 0 Comment | 17 Apr, 2020
There is no specific drug which can fight against COVID-19 yet. Developing a specific drug is quite tough. It is no...Read more
-
Fujifilm accelerates favipiravir production for COVID-19 treatment
Drug Discovery | News | 0 Comment | 16 Apr, 2020
Fujifilm is ramping up production of its antiviral treatment drug favipiravir, one of many approved drugs being tested...Read more
-
Australia’s CDD Cures Crohn’s Disease
Drug Discovery | News | 1 Comment | 15 Apr, 2020
The Centre for Digestive Disease (CDD) headed by Professor Thomas Borody has cured Crohn’s Disease as reported on ...Read more
-
Pfizer Advances Battle Against COVID-19 on Multiple Fronts
Drug Discovery | News | 0 Comment | 10 Apr, 2020
Pfizer Inc.on 9 April 2020, announced important advances in the battle against the global COVID-19 pandemic. Some o...Read more
-
Takeda and CSL Behring to Develop Potential COVID-19 Hyperimmune Therapy
Drug Discovery | News | 0 Comment | 10 Apr, 2020
Takeda and CSL Behring, a provider of plasma-derived and recombinant therapies based in King of Prussia, PA, on 6 April ...Read more
-
I-Mab to develop TJM2 for treatment of COVID-19 related illness
Drug Discovery | News | 0 Comment | 26 Mar, 2020
I-Mab Biopharma, a clinical stage biopharmaceutical company committed to the discovery, development and commercializatio...Read more
-
CytomX, Astellas to find cure for cancer
Drug Discovery | News | 0 Comment | 25 Mar, 2020
US based CytomX Therapeutics and Japan based Astellas Pharma have entered into a strategic collaboration agreement focus...Read more
-
China clears Taletrectinib IND, issues clinical trial authorizations
Drug Discovery | News | 0 Comment | 24 Mar, 2020
AnHeart Therapeutics, a clinical stage oncology company focused on underserved patients in global markets, has anno...Read more
-
Bayer, Curadev ink €250M deal for novel STING antagonists
Drug Discovery | News | 0 Comment | 24 Mar, 2020
Bayer and Curadev Pvt. Ltd., a drug discovery company based in India, on 23 March 2020 announced a research collaboratio...Read more
-
Japan approves Novartis' SMA drug
Drug Discovery | News | 0 Comment | 19 Mar, 2020
Novartis Pharma has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved Zolgensma (o...Read more
-
Beijing Tide Pharma collaborates with Insilico for cancer therapy
Drug Discovery | News | 0 Comment | 18 Mar, 2020
Beijing Tide Pharmaceutical Co., Ltd. (Tide), a subsidiary of Sino Biopharmaceutical Limited, and Insilico Med...Read more
-
Japan to test AIM ImmunoTech’s Ampligen for COVID-19
Drug Discovery | News | 0 Comment | 10 Mar, 2020
AIM ImmunoTech, an immunopharmaceutical company focused on the development of immunological, viral and multiple cancer t...Read more
-
Atomwise, Bridge Bio sign $1B Deal
Drug Discovery | News | 0 Comment | 12 Mar, 2020
US based Atomwise, the leader in using artificial intelligence (AI) for small molecule discovery, and South Korea based ...Read more
-
Takeda initiates development of Plasma-Derived Therapy for COVID-19
Drug Discovery | News | 0 Comment | 05 Mar, 2020
Japan based Takeda Pharmaceutical Company will share with members of the United States Congress that it is initiating th...Read more
-
Eisai, FUJI YAKUHIN to work on hyperuricemia and gout treatment
Drug Discovery | News | 1 Comment | 27 Feb, 2020
Japan based Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD. have concluded a license agreement concerning dotinurad (ge...Read more
